Overview

Inflammatory Regulation Effect of NAC on COVID-19 Treatment

Status:
Not yet recruiting
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
Study times to evaluate the efficacy of N-Acetylcysteine therapy in the management of adult admitted patients with COVID-19.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Tariq Alhawassi
Treatments:
Acetylcysteine
N-monoacetylcystine